<DOC>
	<DOC>NCT00668135</DOC>
	<brief_summary>To demonstrate the efficacy, safety and tolerability of 10 mg oral vardenafil (BAY 38-9456) compared to placebo for a period of 12 weeks in men with erectile dysfunction (ED)</brief_summary>
	<brief_title>Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Age: 20 years and older Males with erectile dysfunction Stable heterosexual relationship Primary hypoactive sexual desire History of myocardial infarction, stroke or lifethreatening arrhythmia within the prior 6 months Nitrate use Other exclusion criteria apply according to the Summary of Product Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Vardenafil</keyword>
</DOC>